Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Wisconsin Participates in START Trial

From U.S. Centers for Disease Control and Prevention

May 17, 2011

Researchers from the Medical College of Wisconsin are taking part in Phase IV of the international Strategic Timing of Antiretroviral Treatment clinical trial, which seeks to determine the best time for asymptomatic persons with HIV to begin taking medications. The study, called START, has a goal of enrolling 4,000 HIV-positive men and women in 30 nations. For more information, visit www.mcw.edu/publicaffairs/NewsCenter/CollegeNews/ResearcherstoparticipateinglobalAIDSclinicaltrial.htm.

Back to other news for May 2011

Adapted from:
Milwaukee Journal-Sentinel
04.14.2011


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
 
See Also
Specific U.S. Nationwide Studies
No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement